EVOREL 75

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

ESTRADIOL AS HEMIHYDRATE 4.8 MG

Disponible desde:

J-C HEALTH CARE LTD

Código ATC:

G03CA03

formulario farmacéutico:

PATCHES

Vía de administración:

TRANSDERMAL

Fabricado por:

JANSSEN PHARMACEUTICA N.V.,BELGIUM

Grupo terapéutico:

ESTRADIOL

indicaciones terapéuticas:

Deficiency symptoms by absence of Estrogen after the menopause or after surgical removal of the ovarians. They comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis.In women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

Fecha de autorización:

2009-08-01